A study on Acarbose and Myo-inositol combination therapy on the complications of PCOS.
- Conditions
- Health Condition 1: E89-E89- Postprocedural endocrine and metabolic complications and disorders, not elsewhere classified
- Registration Number
- CTRI/2022/04/041877
- Lead Sponsor
- SRM College of Pharmacy SRM Institute of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
a) Subjects diagnosed with PCOS based on Rotterdam criteria such as chronic anovulation- oligomenorrhea or amenorrhea, clinical or biochemical hyperandrogenism, polycystic ovarian morphology by transvaginal ultrasound.
b) Subjects with IR ( fasting glucose: insulin ratio < 4.5)
c) Subjects with aged 18 to 39
d) Subjects with BMI > 25
e) Subjects with willingness to provide informed consent will be included in the study.
a) Subjects with diseases and conditions that mimic PCOS such as Cushing syndrome, congenital adrenal hyperplasia, idiopathic hirsutism, prolactinoma, acromegaly, type 2 DM, ovarian and adrenal androgen secreting tumours.
b) Subjects on Oral contraceptives, glucocorticoids, antiandrogen, ovulation induction tablets, anti-diabetes, anti-obesity drugs for the past 3 months will be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method